The high level of underdiagnosis in COPD, which is around 75%, entails a great loss of opportunity to reduce the natural evolution of the disease, to identify subjects susceptible to develop more advanced stages of COPD and to lose therapeutic resources (early smoking advice and pharmacological treatment). Spirometry is a fundamental tool for the diagnosis and monitoring of respiratory diseases and is essential for the diagnosis of COPD (FEV1 / FVC ratio